Last reviewed · How we verify

NCT05113056: PFA-AF

AcQForce Pulsed Field Ablation-CE

Completed NA Last updated 13 November 2023
What this trial tests

NA trial testing Acutus Medical Pulsed Field Ablation System in Atrial Arrhythmia in 24 participants. Completed in 16 March 2023.

Timeline
11 November 2021
Primary endpoint
16 March 2023
16 March 2023

Quick facts

Lead sponsorAcutus Medical
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment24
Start date11 November 2021
Primary completion16 March 2023
Estimated completion16 March 2023
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Acutus Medical

Who can join

Adults 18 to 80, any sex, with Atrial Arrhythmia or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Pulsed Field Ablation System Study for Atrial Fibrillation (PFA-AF)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Arrhythmia

Currently open trials in the same condition.

Other Acutus Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05113056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing